We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.6%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$27.1B
AUM Growth
+$3.44B
Cap. Flow
+$921M
Cap. Flow %
3.4%
Top 10 Hldgs %
34.67%
Holding
1,351
New
69
Increased
716
Reduced
273
Closed
50

Top Sells

Rank Stock Value
1
OHI icon
Omega Healthcare
OHI
+$137M
2
AMT icon
American Tower
AMT
+$116M
3
PSA icon
Public Storage
PSA
+$97.9M
4
UDR icon
UDR
UDR
+$80.4M
5
AVB icon
AvalonBay Communities
AVB
+$73.9M

Sector Composition

Rank Sector Weight
1 Real Estate 30.73%
2 Technology 27.75%
3 Communication Services 10.3%
4 Consumer Discretionary 6.75%
5 Financials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMPH icon
1151
Amphastar Pharmaceuticals
AMPH
$881M
$4K ﹤0.01%
185
AUPH icon
1152
Aurinia Pharmaceuticals
AUPH
$1.92B
$4K ﹤0.01%
528
CAAP icon
1153
Corporacion America
CAAP
$4.27B
$4K ﹤0.01%
+183
New +$3.6K
CNTA
1154
DELISTED
Centessa Pharmaceuticals
CNTA
$4K ﹤0.01%
294
COLL icon
1155
Collegium Pharmaceutical
COLL
$1.16B
$4K ﹤0.01%
127
CVAC
1156
DELISTED
CureVac
CVAC
$4K ﹤0.01%
697
DBC icon
1157
Invesco DB Commodity Index Tracking Fund
DBC
$1.65B
$4K ﹤0.01%
200
DVAX
1158
DELISTED
Dynavax Technologies
DVAX
$4K ﹤0.01%
409
DYN icon
1159
Dyne Therapeutics
DYN
$4.27B
$4K ﹤0.01%
371
GRFS
1160
Grifois
GRFS
$5.3B
$4K ﹤0.01%
398
IMCR icon
1161
Immunocore
IMCR
$1.7B
$4K ﹤0.01%
138
JANX icon
1162
Janux Therapeutics
JANX
$901M
$4K ﹤0.01%
187
KNSA icon
1163
Kiniksa Pharmaceuticals
KNSA
$6.09B
$4K ﹤0.01%
139
MNKD icon
1164
MannKind Corp
MNKD
$1.2B
$4K ﹤0.01%
1,058
NVAX icon
1165
Novavax
NVAX
$1.22B
$4K ﹤0.01%
652
PCRX icon
1166
Pacira BioSciences
PCRX
$1.06B
$4K ﹤0.01%
169
TVTX icon
1167
Travere Therapeutics
TVTX
$5.19B
$4K ﹤0.01%
258
TXG icon
1168
10x Genomics
TXG
$5.9B
$4K ﹤0.01%
370
VERA icon
1169
Vera Therapeutics
VERA
$2.41B
$4K ﹤0.01%
182
VERV
1170
DELISTED
Verve Therapeutics
VERV
$4K ﹤0.01%
321
-10,189
-97% -$58.1K
XLF icon
1171
State Street Financial Select Sector SPDR ETF
XLF
$57.3B
$4K ﹤0.01%
72
+5
+7% +$247
XLV icon
1172
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
$4K ﹤0.01%
33
-2
-6% -$270
ZYME icon
1173
Zymeworks
ZYME
$1.65B
$4K ﹤0.01%
286
ARDX icon
1174
Ardelyx
ARDX
$1.25B
$3K ﹤0.01%
754
AVDL
1175
DELISTED
Avadel Pharmaceuticals
AVDL
$3K ﹤0.01%
332

Similar funds

Daiwa Securities Group's Q2 2025 Portfolio in Review

As of Q2 2025, Daiwa Securities Group held 1,351 positions worth $27.1B, up 15% from $23.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $921M of net new capital in Q2 2025, opening 69 new positions and adding to 716 existing holdings. Its largest new stake was SmartStop Self Storage REIT: 313,858 shares worth $11.4M.

By sector, the portfolio is most concentrated in Real Estate at 31% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Omega Healthcare, an estimated $137M trimmed.

  • Daiwa Securities Group's largest Q2 2025 buy was SmartStop Self Storage REIT: 313,858 shares worth $11.4M.
  • Daiwa Securities Group added most to Apple in Q2 2025, an estimated $162M increase.
  • Daiwa Securities Group's biggest Q2 2025 reduction was Omega Healthcare, cutting an estimated $137M.
  • Daiwa Securities Group fully exited iShares Core US Aggregate Bond ETF in Q2 2025, selling an estimated $10.3M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $27.1B portfolio in Q2 2025.
  • Daiwa Securities Group opened 69 new positions and closed 50 in Q2 2025.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $27.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2025, filed 14 Aug 2025.